Name
Safe Rx Opioid and Naloxone Dispensing Toolkit: Pilot Study Results
Date & Time
Wednesday, April 4, 2018, 2:00 PM - 3:15 PM
Speakers
Dan Hartung, PharmD, MPH, Associate Professor of Pharmacy, Oregon State University / Oregon Health & Science University College of Pharmacy
Nicole O'Kane, PharmD, Clinical Director, HealthInsight Oregon
Nicole O'Kane, PharmD, Clinical Director, HealthInsight Oregon
Description
Moderator: CeCe Spitznas, PhD, Senior Science Policy Advisor, Office of National Drug Control Policy, and Member, National Rx Drug Abuse & Heroin Summit
CE Certified By: AAFP,ACPE
This presentation will provide results from the RESPOND Toolkit pilot study, which was introduced at the 2017 National Rx Drug Abuse & Heroin Summit. Results highlight the importance of training tailored to community pharmacists to promote psychological and behavioral shifts supporting greater opioid safety for patients.
The RESPOND Toolkit, which is funded by the Agency for Healthcare Quality and Research, enhances community pharmacists’ understanding of their role in addressing opioid safety; improves integration of prescription drug monitoring programs (PDMP) into daily workflow; and enhances communication between pharmacists, prescribers and patients. The toolkit consists of an online continuing education course and printed materials. Preliminary focus groups and participant interviews performed mid-study shaped the final content, flow and delivery of the toolkit. The RESPOND Toolkit was tested in six community pharmacies in Oregon using a quasi-experimental design. Pre- and post-surveys assessed RESPOND’s effectiveness in positively impacting pharmacists’ knowledge, attitudes, perceived behavioral control and self-efficacy. State PDMP data were used to examine changes in store-level PDMP query rates and opioid dispensing behavior.
UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Describe educational components of the RESPOND Toolkit.
- Explain findings from the RESPOND Toolkit pilot study.
- Discuss implications of RESPOND pilot study findings on community pharmacy practice.
CE Certified By: AAFP,ACPE
This presentation will provide results from the RESPOND Toolkit pilot study, which was introduced at the 2017 National Rx Drug Abuse & Heroin Summit. Results highlight the importance of training tailored to community pharmacists to promote psychological and behavioral shifts supporting greater opioid safety for patients.
The RESPOND Toolkit, which is funded by the Agency for Healthcare Quality and Research, enhances community pharmacists’ understanding of their role in addressing opioid safety; improves integration of prescription drug monitoring programs (PDMP) into daily workflow; and enhances communication between pharmacists, prescribers and patients. The toolkit consists of an online continuing education course and printed materials. Preliminary focus groups and participant interviews performed mid-study shaped the final content, flow and delivery of the toolkit. The RESPOND Toolkit was tested in six community pharmacies in Oregon using a quasi-experimental design. Pre- and post-surveys assessed RESPOND’s effectiveness in positively impacting pharmacists’ knowledge, attitudes, perceived behavioral control and self-efficacy. State PDMP data were used to examine changes in store-level PDMP query rates and opioid dispensing behavior.
UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Describe educational components of the RESPOND Toolkit.
- Explain findings from the RESPOND Toolkit pilot study.
- Discuss implications of RESPOND pilot study findings on community pharmacy practice.